Alkermes Plc (NASDAQ:ALKS)

45.77
Delayed Data
As of May 25
 +0.35 / +0.77%
Today’s Change
41.15
Today|||52-Week Range
71.22
-16.37%
Year-to-Date
No recent news for Alkermes Plc.

Today’s Trading

Previous close45.42
Today’s open45.52
Day’s range45.36 - 46.19
Volume419,126
Average volume (3 months)1,143,846
Market cap$7.3B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+25.36%
Earnings growth (this year)-86.11%
Earnings growth (next 5 years)+45.25%
Revenue growth (last year)+21.15%
P/E ratioNM
Price/Sales9.29
Price/Book6.02

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+1.01+1.02%
SGENSeattle Genetics Inc+0.42+0.76%
TSROTESARO Inc+3.18+6.55%
JAZZJazz Pharmaceuticals...+1.44+0.88%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)$0.06
Annual revenue (last year)$903.4M
Annual profit (last year)-$157.9M
Net profit margin-17.48%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President &
Chief Operating Officer
James Robinson
Corporate headquarters
Dublin, Dublin

Forecasts